Assist. Prof. Dr. Arshad Islam | Nanomedicine | Best Researcher Award

Assistant Professor at Lady Reading Hospital Medical Teaching Institution Peshawar, Pakistan

Dr. Arshad Islam is an Assistant Professor & Consultant in Biochemistry at the Department of Pathology, Lady Reading Hospital (LRH), Peshawar, Pakistan. He is an HEC-Pakistan approved PhD supervisor and an expert in nanomedicine, drug discovery, and delivery systems 🧪. With postdoctoral research experience in Brazil 🇧🇷, he specializes in developing nanoscale drug carriers for treating parasitic diseases like leishmaniasis and trypanosomiasis. Passionate about teaching, research, and interdisciplinary collaboration, he actively supervises students, manages research projects, and serves on multiple institutional committees. His expertise spans biochemistry, bioinorganic chemistry, pharmacokinetics, and molecular biology. 🔬

Professional Profile:

Orcid

Scopus

Google Scholar

Education & Experience 🎓🔬

Education 📚

• Ph.D. in Biochemistry/Biological Chemistry (2010–2014) – Universidade Federal de Minas Gerais, Brazil 🇧🇷

  • Research: Novel organoantimony(V) & organobismuth(V) complexes for antimicrobial and anticancer applications

• M.Phil. in Biochemistry & Molecular Biology (2007–2009) – Quaid-i-Azam University, Islamabad, Pakistan 🇵🇰

  • Research: Cardiovascular Risk Elements in the Asian Population

• B.S. (Hons.) in Biotechnology (2003–2007) – University of Peshawar, Pakistan

Experience 🏥👨‍🔬

• Assistant Professor & Consultant, Biochemistry (2020–Present) – LRH-MTI, Peshawar

  • Oversees chemical pathology, molecular biology, blood bank, infection control, and research committees

• Assistant Professor, Biosciences (2019–2020) – IIU, Islamabad

  • Specialized in drug discovery, nanomedicine, and teaching postgraduate courses

• Postdoctoral Fellow (2014–2018) – Brazil

  • Universidade Federal de Minas Gerais & Universidade Federal de Ouro Preto 🇧🇷

  • Research in nano-drug delivery, parasitic diseases, pharmacokinetics, and biophysics

Professional Development 🌍📖

Dr. Arshad Islam has demonstrated exceptional expertise in research and academia, contributing significantly to drug discovery, nanomedicine, and molecular biochemistry. His postdoctoral research in Brazil focused on designing cationic nanosystems for targeted antileishmanial and anticancer therapies 🦠. With a strong teaching background, he has supervised undergraduate and postgraduate students, developed innovative curricula, and participated in multidisciplinary research collaborations 🧬. As a member of various institutional research and regulatory committees, he ensures compliance with biosafety protocols and ethical standards. His passion for scientific inquiry, laboratory management, and grant writing continues to drive impactful research and medical advancements. 🚀

Research Focus 🔬🧪

Dr. Arshad Islam specializes in nanomedicine, bioinorganic chemistry, and drug delivery systems, with a strong focus on parasitic diseases, bacterial infections, and cancer treatment 🏥. His research involves:

• Developing nanoscale drug carriers for enhanced drug solubility, targeting, and bioavailability

• Studying drug interactions with biomolecules (DNA, proteins, enzymes) to understand mechanisms of action & resistance 🧬

• Innovating amphiphilic metal complexes for leishmaniasis & trypanosomiasis treatment 🦠

• Investigating pharmacokinetics & biochemistry of drug absorption, metabolism, and clearance
  Through interdisciplinary collaboration, he aims to develop advanced therapeutic strategies to combat infectious diseases and drug-resistant pathogens. 🌍💊

Awards & Honors 🏆🎖

• Postdoctoral Fellowships (2014–2018) – Brazil 🇧🇷 (CAPES, CNPq, FAPEMIG)

• TWAS/CNPq PhD Fellowship (2010–2014) – Brazil 🌍

• HEC-Indigenous M.Phil. Fellowship (2007–2009) – Pakistan 🏅

• Research Grant Awards for Drug Discovery & Nanomedicine 💰

• Institutional Research Board & Scientific Committee Memberships 📜

• Keynote Speaker & Presenter at International Conferences 🎤

Publication Top Notes

1. In Vitro and In Silico Assessment of Antileishmanial Potential of Novel Tri‐ and Penta‐Valent Antimony Complexes With Phenolic Ligands

   • Published In: Drug Development Research (February 2025)

   • DOI: 10.1002/ddr.70067

   • Summary: This study reports the synthesis and evaluation of four novel antimony complexes (3a‐3d) as potent and safe antileishmanial agents. The complexes were synthesized using antimony salts with different phenolic ligands and characterized by elemental analysis, FT‐IR, and NMR spectroscopic techniques. Both in vitro and in silico assessments were conducted to determine their efficacy against Leishmania parasites. ​

2. Susceptibility of Leishmania to Novel Pentavalent Organometallics: Investigating Impact on DNA and Membrane Integrity in Antimony(III)-Sensitive and -Resistant Strains

   • Published In: Drug Development Research (May 2024)

   • DOI: 10.1002/ddr.22194

   • Summary: This research explores the effects of novel pentavalent antimony compounds on DNA and membrane integrity in both antimony(III)-sensitive and -resistant Leishmania strains. The study aims to understand the mechanisms of action and potential resistance pathways associated with these organometallic compounds.​

3. Syzygium cumini-Mediated Green Synthesis of Magnesium Oxide Nanoparticles and Evaluation of Their Antibacterial, Antileishmanial, and Antioxidant Activities

   • Published In: Futuristic Biotechnology (March 31, 2024)

   • DOI: 10.54393/fbt.v4i01.63

   • Summary: This study investigates the green synthesis of magnesium oxide nanoparticles using Syzygium cumini (commonly known as Jamun) extract. The synthesized nanoparticles were evaluated for their antibacterial, antileishmanial, and antioxidant activities, highlighting their potential as multifunctional therapeutic agents.​

4. Biomedical Applications of Green Synthesized Zinc Oxide and Magnesium-Doped Zinc Oxide Nanoparticles Using Aqueous Extract of Ziziphus oxyphylla Leaves

   • Published In: IEEE Transactions on Nanobioscience (March 12, 2024)

   • DOI: 10.1109/tnb.2024.3373777

   • Summary: This research focuses on the green synthesis of zinc oxide and magnesium-doped zinc oxide nanoparticles using aqueous extracts of Ziziphus oxyphylla leaves. The study evaluates their biomedical applications, including antimicrobial and antileishmanial activities, suggesting their potential in nanomedicine.​

5. Comparative Analysis of the Severity and Progression of Cutaneous Leishmaniasis Caused by Leishmania tropica in Untreated and Glucantime-Treated Patients

   • Published In: Acta Tropica (December 2023)

   • DOI: 10.1016/j.actatropica.2023.107023

   • Summary: This study examines the severity and progression of cutaneous leishmaniasis caused by Leishmania tropica in patients who were either untreated or treated with Glucantime (a pentavalent antimonial drug). The findings provide insights into the efficacy of Glucantime and the natural progression of the disease.

Conclusion

Dr. Arshad Islam’s contributions to drug discovery, nanotechnology-based drug delivery, and infectious disease treatment make him an outstanding candidate for the Best Researcher Award. His combination of international experience, innovative research, academic leadership, and impactful publications strongly supports his recognition as a leading researcher in his field.